Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic variables in canine multicentric lymphosarcoma.

J M Dobson1, L B Blackwood, E F McInnes

  • 1Queen's Veterinary School Hospital, University of Cambridge.

The Journal of Small Animal Practice
|August 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Significant advances in veterinary oncology - 60 years on.

The Journal of small animal practice·2019
Same author

Geographic distribution and environmental risk factors of lymphoma in dogs under primary-care in the UK.

The Journal of small animal practice·2019
Same author

The future of radiotherapy in small animals - should the fractions be coarse or fine?

The Journal of small animal practice·2018
Same author

Temporal and spatial heterogeneity in milk and immune-related gene expression during mammary gland involution in dairy cows.

Journal of dairy science·2017
Same author

Glycolysis inhibition improves photodynamic therapy response rates for equine sarcoids.

Veterinary and comparative oncology·2017
Same author

Cell survival signaling in the bovine mammary gland during the transition from lactation to involution.

Journal of dairy science·2016

Prognostic factors for canine multicentric lymphosarcoma were evaluated. Tumor immunophenotype, specifically T-cell versus B-cell, significantly impacted survival in dogs treated with standard chemotherapy.

Area of Science:

  • Veterinary Oncology
  • Canine Cancer Research
  • Lymphoma Immunophenotyping

Background:

  • Multicentric lymphosarcoma is a common cancer in dogs.
  • Standard chemotherapy protocols exist but prognostic indicators require further investigation.
  • Understanding prognostic factors can guide treatment decisions and improve outcomes.

Purpose of the Study:

  • To assess the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count, and nucleolar organizer region counts.
  • To identify predictors of treatment response and relapse-free survival in dogs with multicentric lymphosarcoma.
  • To evaluate the impact of various tumor and patient variables on treatment outcomes.

Main Methods:

  • Prospective study involving 49 dogs with multicentric lymphosarcoma.

Related Experiment Videos

  • Standard chemotherapy protocol: vincristine, cyclophosphamide, and prednisolone.
  • Univariate and multivariate regression analysis to evaluate prognostic importance of variables.

    • Main Results:

    • 76% of dogs achieved complete remission, 14% partial remission, and 10% failed to respond.
    • No examined variable significantly affected tumor response.
    • Tumor immunophenotype was the sole significant predictor of patient survival (P=0.035).

    Conclusions:

    • Tumor immunophenotype is a critical prognostic factor for survival in canine multicentric lymphosarcoma.
    • Clinical and histological factors did not significantly predict treatment response or survival in this cohort.
    • Further research into T-cell versus B-cell lymphosarcoma is warranted to optimize canine cancer therapy.